Canada’s government and health science sectors should commit to researching the health effects of oil sands tailings, as previous research suggests that air, water, and land contaminations negatively affect local people’s health, authors urge in a CMAJ (Canadian Medical Association Journal) commentaryhttps://www.cmaj.ca/lookup/doi/10.1503/cmaj.240643.

Led by Marc Murray, who completed the study as part of his PhD in the School of Physical Education, Sport and Exercise Sciences, researchers aimed to build on earlier research about how exercise and protein influence Insulin-like growth factor 1 (IGF-1). IGF-1 is a hormone that possesses anabolic effects, relating to protein synthesis, which play a role in muscle development and repair.

Research from Edith Cowan University (ECU) has revealed that both resistance training and high intensity interval training (HIIT) produced sufficient levels of myokines to help in the fight against cancer. 

A specialist form of therapy could offer hope for some of the most vulnerable young PTSD sufferers – according to a University of East Anglia study.

Researchers investigated the effectiveness of trauma-focused cognitive-behavioural therapy (CBT) for treating children who had been through multiple traumas such as abuse, violence or serious accidents.

While this type of therapy is already known to help with PTSD, the new study focused on children who had experienced multiple traumas - a group often considered harder to treat.

The large clinical trial is one of the first of its kind to test this approach in real-world settings. The research team hope that this therapy could offer a lifeline to some of the most vulnerable young people.

A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with obesity, including those with type 2 diabetes (T2D), according to the results of two large-scale, international phase 3 clinical trials. The findings, published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people with obesity, including those with T2D, who have not achieved sufficient weight loss with existing treatments.